E

Encore Medical, Inc.

EMIFiled

Encore Medical, Inc. · Exchange pending · Research source · S-1/A · 2026-09-28 · Latest filing · S-1/A · 2026-11-16 SEC ↗

Report source
Research source · S-1/A · 2026-09-28
SummaryBASIC RESEARCHReport source · S-1/A

Encore Medical advances a conditional IPO while losses, liquidity needs, and regulatory execution remain material.

As of the September 28, 2026 S-1/A, Encore Medical proposed a $5.00 IPO for 3,000,000 shares, subject to completion and NYSE American listing.

Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointEffectiveness, final pricing, closing, listing and trading remain unconfirmed; no verified date is supplied.S-1/A · 2026-09-28
Business and development direction

Encore Medical, Inc.

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

The company has no U.S. marketing approval; failure or delay in the stroke trial and PMA process could prevent U.S. commercialization.

Risk 2

The auditor’s going-concern doubt and management’s need for additional equity financing create a material funding dependency.

Risk 3

Product liability events could cause legal costs, recalls, regulatory scrutiny and loss of physician or patient confidence.

Next checkEffectiveness, final pricing, closing, listing and trading remain unconfirmed; no verified date is supplied.
Latest filing2026-11-16
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSUnderwriters named in the prospectus
PRELIMINARY
#InstitutionUnderwriting allocationRatioShares
1The Oak Ridge Financial Services Group, Inc.
2Network 1 Financial Securities, Inc.
Source and calculation

Names are explicitly identified in source underwriting tables or role clauses. Quantities require the named firm's own table row; missing allocations are not inferred.

Source · S-1/A ↗

Underwriting terms

Underwriting terms
MeasureReported valueUnit
Underwriting discount per share$0.4$ / share
Total underwriting discount$1,200,000$
Source and calculation

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Underwriting discount per share

Base prospectus offering; cover per-share and total columns

SEC table 4 row 3; source 26516:33109; SHA256 6bcbb5c4822d303474cad878dc0eeda62042e9f2b94d1be414c834943c76a484 ↗

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Total underwriting discount

Base prospectus offering; cover per-share and total columns

SEC table 4 row 3; source 26516:33109; SHA256 6bcbb5c4822d303474cad878dc0eeda62042e9f2b94d1be414c834943c76a484 ↗

IPO CAPITAL QUALITY

Offering price $ / share$5
Gross offering amount $$15,000,000
Issuer proceeds before expenses $$13,800,000
Underwriting discount per share $ / share$0.4
Basis and evidence

S-1/A · 2026-09-28

As of the September 28, 2026 S-1/A, Encore Medical proposed a $5.00 IPO for 3,000,000 shares, subject to completion and NYSE American listing.

Offering structure

Offering terms
MeasureReported valueUnit
Primary shares · Encore Medical, Inc.3,000,000Shares
Offering price$5$ / share
Gross offering amount$15,000,000$
Source and calculation

Shares sold by the issuer; base offering Reported inputs; each row retains its own source basis.

Primary shares · Encore Medical, Inc.

Shares sold by the issuer; base offering

Prospectus Summary ↗

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Gross offering amount

Base prospectus offering; cover per-share and total columns

SEC table 4 row 2; source 26516:33109; SHA256 6bcbb5c4822d303474cad878dc0eeda62042e9f2b94d1be414c834943c76a484 ↗

Proceeds and intended uses

Proceeds and intended uses
MeasureReported valueUnit
Issuer proceeds before expenses$13,800,000$
Source and calculation

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Issuer proceeds before expenses

Base prospectus offering; cover per-share and total columns

SEC table 4 row 4; source 26516:33109; SHA256 6bcbb5c4822d303474cad878dc0eeda62042e9f2b94d1be414c834943c76a484 ↗

Dilution and valuation

IPO price$5Price status unverified
Basic post-offer≈ 10.7434M
Equity value—

Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.

Dilution and valuation
CalculationSharesValueReference
Post-offer shares · Encore Medical, Inc.10,743,425—
Reported sourceEncore Medical, Inc.sharesBasis and evidence 1 ↗
Capitalization shares — actual5,867,425—
Reported sourceCommon Stock; actualsharesBasis and evidence 2 ↗
Capitalization shares — pro forma6,743,425—
Reported sourceCommon Stock; pro formasharesBasis and evidence 3 ↗
Capitalization shares — pro forma as adjusted10,743,425—
Reported sourceCommon Stock; pro forma as adjustedsharesBasis and evidence 4 ↗
Post-offer shares — base/no option10,743,425—
Reported sourcePost-offer · BasesharesBasis and evidence 5 ↗
Post-offer shares — full option11,193,425—
Reported sourcePost-offer · Full optionsharesBasis and evidence 6 ↗
Offering price—$5
Reported sourcePrice status unverified$/shareBasis and evidence 7 ↗
Gross offering amount—$15,000,000
Reported source$Basis and evidence 7 ↗
Primary shares · Encore Medical, Inc.3,000,000—
Reported sourcesharesBasis and evidence 1 ↗
Basis and evidence ↗
Basis and evidence 1

Immediately after offering; no overallotment

Reported inputs; each row retains its own source basis.

Exact input · Primary shares · Encore Medical, Inc.: 3,000,000

Prospectus Summary ↗

Basis and evidence 2

Capitalization share count; source stage: actual; Common Stock, par value $.01 par value; 20,000,000 shares authorized, 5,867,425 shares issued and outstanding, actual; 6,743,425 shares issued and outstanding, pro forma; 10,743,425 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator

Figures retain their stated source scenario and conditions.

SEC table 9 row 6 columns 1; share summary; label column 1; source 403657:426783; SHA256 1cb284185f2fab3f2c0c1b2cb6051292807e94706562e4d8ce8b3a1f2f01b744 ↗

Basis and evidence 3

Capitalization share count; source stage: pro forma; Common Stock, par value $.01 par value; 20,000,000 shares authorized, 5,867,425 shares issued and outstanding, actual; 6,743,425 shares issued and outstanding, pro forma; 10,743,425 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator

Figures retain their stated source scenario and conditions.

SEC table 9 row 6 columns 1; share summary; label column 1; source 403657:426783; SHA256 1cb284185f2fab3f2c0c1b2cb6051292807e94706562e4d8ce8b3a1f2f01b744 ↗

Basis and evidence 4

Capitalization share count; source stage: pro forma as adjusted; Common Stock, par value $.01 par value; 20,000,000 shares authorized, 5,867,425 shares issued and outstanding, actual; 6,743,425 shares issued and outstanding, pro forma; 10,743,425 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator

Figures retain their stated source scenario and conditions.

SEC table 9 row 6 columns 1; share summary; label column 1; source 403657:426783; SHA256 1cb284185f2fab3f2c0c1b2cb6051292807e94706562e4d8ce8b3a1f2f01b744 ↗

Basis and evidence 5

Prospectus share summary; Common stock outstanding immediately after this offering; 10,743,425 shares, or 11,193,425 shares if the underwriters exercise the over-allotment option in full.; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

Exact input · Post-offer shares — base/no option: 10,743,425

SEC offering-summary columns; container 143000:151038 SHA256 68158fae5c21b5344aa2e559c9dd4beaeab1efdc68d513a9199d21422c5a5f20; label 146907:147259 SHA256 00917d6af716bfed62bc2c107b61877c377096980cc4329d0512a59cd21d5430; value 147273:147555 SHA256 9cfe4729b997e1caf474b4a8b6db7a02d9d73de3fb6aab9f58641ad8bc4288c9; source 146907:147555; SHA256 86cf30ea5aeca04e0b8f44264974e41c1c6fac2aceec5b1f619a0c53cec728fa ↗

Basis and evidence 6

Prospectus share summary; Common stock outstanding immediately after this offering; 10,743,425 shares, or 11,193,425 shares if the underwriters exercise the over-allotment option in full.; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC offering-summary columns; container 143000:151038 SHA256 68158fae5c21b5344aa2e559c9dd4beaeab1efdc68d513a9199d21422c5a5f20; label 146907:147259 SHA256 00917d6af716bfed62bc2c107b61877c377096980cc4329d0512a59cd21d5430; value 147273:147555 SHA256 9cfe4729b997e1caf474b4a8b6db7a02d9d73de3fb6aab9f58641ad8bc4288c9; source 146907:147555; SHA256 86cf30ea5aeca04e0b8f44264974e41c1c6fac2aceec5b1f619a0c53cec728fa ↗

Basis and evidence 7

Base prospectus offering; cover per-share and total columns

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Exact input · Offering price: $5

SEC table 4 row 2; source 26516:33109; SHA256 6bcbb5c4822d303474cad878dc0eeda62042e9f2b94d1be414c834943c76a484 ↗

Share-count comparison

A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Source inputs required

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Source ↗
Implied equity value—Price × post-offer shares
Post-offer shares—Share count, not tradable float
Existing-holder ownership reduction—Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Reported point prices retain their security, class, currency and per-security unit; range endpoints remain separate.

Base post-offer shares

Reported whole-issuer base counts retain explicit option, conversion and surrender assumptions.

Equity value

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Share-count change

A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.

Alternative scenarios

Each reported full-option, actual, diluted or class-specific case remains independent; no class sum or cross-date substitution is inferred.

Sensitivity

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-09-28
!Officers and directors are expected to retain 27.0% collectively and Joseph Marino with family members approximately 15.5%, based on beneficial ownership rules and no overallotment. Voting rights by holder and sponsor-style holdings are not supplied. Series A conversion is 876,000 shares immediately before closing and is included in post-offering shares.View source ↗
Relationship filters
Show
ownership / voting rights
share structure
Select for details · Encore Medical, Inc.
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
Joseph A. MarinoBeneficial shares1,893,395——
Pre-Offering; Shares OwnedDisclosedEvidence
Joseph A. MarinoBeneficial shares1,893,395——
Post-Offering; Shares OwnedDisclosedEvidence
Peter M. BuonomoBeneficial shares200,000——
Pre-Offering; Shares OwnedDisclosedEvidence
Peter M. BuonomoBeneficial shares200,000——
Post-Offering; Shares OwnedDisclosedEvidence
Scott S. RobinsonBeneficial shares100,000——
Pre-Offering; Shares OwnedDisclosedEvidence
Scott S. RobinsonBeneficial shares100,000——
Post-Offering; Shares OwnedDisclosedEvidence
Christopher J. TurnbullBeneficial shares305,505——
Pre-Offering; Shares OwnedDisclosedEvidence
Christopher J. TurnbullBeneficial shares305,505——
Post-Offering; Shares OwnedDisclosedEvidence
Todd C. JohnsonBeneficial shares750,311——
Pre-Offering; Shares OwnedDisclosedEvidence
Todd C. JohnsonBeneficial shares750,311——
Post-Offering; Shares OwnedDisclosedEvidence
Executive Officers and Directors as a Group (6 persons)Beneficial shares3,249,211——
Pre-Offering; Shares OwnedDisclosedEvidence
Executive Officers and Directors as a Group (6 persons)Beneficial shares3,249,211——
Post-Offering; Shares OwnedDisclosedEvidence
Joseph A. MarinoBeneficial ownership—24.4%Beneficial—
Pre-Offering; Percent OwnedDisclosedEvidence
Joseph A. MarinoBeneficial ownership—15.5%Beneficial—
Post-Offering; Percent OwnedDisclosedEvidence
Peter M. BuonomoBeneficial ownership—2.6%Beneficial—
Pre-Offering; Percent OwnedDisclosedEvidence
Peter M. BuonomoBeneficial ownership—1.6%Beneficial—
Post-Offering; Percent OwnedDisclosedEvidence
Scott S. RobinsonBeneficial ownership—1.3%Beneficial—
Pre-Offering; Percent OwnedDisclosedEvidence
Scott S. RobinsonBeneficial ownership—0.8%Beneficial—
Post-Offering; Percent OwnedDisclosedEvidence
Christopher J. TurnbullBeneficial ownership—3.9%Beneficial—
Pre-Offering; Percent OwnedDisclosedEvidence
Christopher J. TurnbullBeneficial ownership—2.5%Beneficial—
Post-Offering; Percent OwnedDisclosedEvidence
Todd C. JohnsonBeneficial ownership—9.7%Beneficial—
Pre-Offering; Percent OwnedDisclosedEvidence
Todd C. JohnsonBeneficial ownership—6.2%Beneficial—
Post-Offering; Percent OwnedDisclosedEvidence
Executive Officers and Directors as a Group (6 persons)Beneficial ownership—41.9%Beneficial—
Pre-Offering; Percent OwnedDisclosedEvidence
Executive Officers and Directors as a Group (6 persons)Beneficial ownership—27%Beneficial—
Post-Offering; Percent OwnedDisclosedEvidence
our officers and directorsOwnership as disclosed—approximately 27.0%Beneficial—
Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares), of which Mr. Marino, our Chairman and CEO, will own, when combined with family members’ ownership, approximately 15.5% of our outstanding common stock following comple; source scope: of our outstanding common stock based on the SEC’s beneficial ownership rules (assuming no exercise of the underwriters’ option to purchase additional shares), of which Mr; not an additive ownership partitionDisclosedEvidence
Mr. Marino — when combined with family members’ ownershipOwnership as disclosed—approximately 15.5%Beneficial—
Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares); source scope: of our outstanding common stock following completion of the offering (assuming no exercise of the underwriters’ option to purchase additional shares); not an additive ownership partitionDisclosedEvidence
common stockper-share voting rights——1 vote per shareVotes per share
Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller findingDisclosedEvidence
Source and calculation ↗
Joseph A. Marino · Joseph A. Marino — Beneficial shares · 1,893,395

Exact source ownership column: Pre-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Shares Owned; source holder: Joseph A. Marino(1)

0001104659-26-111104 · SEC table 22 row 4 columns 6; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:4 ↗

Joseph A. Marino · Joseph A. Marino — Beneficial shares · 1,893,395

Exact source ownership column: Post-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Shares Owned; source holder: Joseph A. Marino(1)

0001104659-26-111104 · SEC table 22 row 4 columns 18; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:10 ↗

Peter M. Buonomo · Peter M. Buonomo — Beneficial shares · 200,000

Exact source ownership column: Pre-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Shares Owned; source holder: Peter M. Buonomo(2)

0001104659-26-111104 · SEC table 22 row 5 columns 6; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:4 ↗

Peter M. Buonomo · Peter M. Buonomo — Beneficial shares · 200,000

Exact source ownership column: Post-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Shares Owned; source holder: Peter M. Buonomo(2)

0001104659-26-111104 · SEC table 22 row 5 columns 18; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:10 ↗

Scott S. Robinson · Scott S. Robinson — Beneficial shares · 100,000

Exact source ownership column: Pre-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Shares Owned; source holder: Scott S. Robinson(3)

0001104659-26-111104 · SEC table 22 row 6 columns 6; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:4 ↗

Scott S. Robinson · Scott S. Robinson — Beneficial shares · 100,000

Exact source ownership column: Post-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Shares Owned; source holder: Scott S. Robinson(3)

0001104659-26-111104 · SEC table 22 row 6 columns 18; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:10 ↗

Christopher J. Turnbull · Christopher J. Turnbull — Beneficial shares · 305,505

Exact source ownership column: Pre-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Shares Owned; source holder: Christopher J. Turnbull(4)

0001104659-26-111104 · SEC table 22 row 7 columns 6; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:4 ↗

Christopher J. Turnbull · Christopher J. Turnbull — Beneficial shares · 305,505

Exact source ownership column: Post-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Shares Owned; source holder: Christopher J. Turnbull(4)

0001104659-26-111104 · SEC table 22 row 7 columns 18; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:10 ↗

Todd C. Johnson · Todd C. Johnson — Beneficial shares · 750,311

Exact source ownership column: Pre-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Shares Owned; source holder: Todd C. Johnson(5)

0001104659-26-111104 · SEC table 22 row 8 columns 6; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:4 ↗

Todd C. Johnson · Todd C. Johnson — Beneficial shares · 750,311

Exact source ownership column: Post-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Shares Owned; source holder: Todd C. Johnson(5)

0001104659-26-111104 · SEC table 22 row 8 columns 18; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:10 ↗

Executive Officers and Directors as a Group (6 persons) · Executive Officers and Directors as a Group (6 persons) — Beneficial shares · 3,249,211

Exact source ownership column: Pre-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Shares Owned; source holder: Executive Officers and Directors as a Group (6 persons)

0001104659-26-111104 · SEC table 22 row 10 columns 6; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:4 ↗

Executive Officers and Directors as a Group (6 persons) · Executive Officers and Directors as a Group (6 persons) — Beneficial shares · 3,249,211

Exact source ownership column: Post-Offering; Shares Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Shares Owned; source holder: Executive Officers and Directors as a Group (6 persons)

0001104659-26-111104 · SEC table 22 row 10 columns 18; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:10 ↗

Joseph A. Marino · Joseph A. Marino — Beneficial ownership · 24.4%

Exact source ownership column: Pre-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Percent Owned; source holder: Joseph A. Marino(1)

0001104659-26-111104 · SEC table 22 row 4 columns 12; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:7 ↗

Joseph A. Marino · Joseph A. Marino — Beneficial ownership · 15.5%

Exact source ownership column: Post-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Percent Owned; source holder: Joseph A. Marino(1)

0001104659-26-111104 · SEC table 22 row 4 columns 24; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:13 ↗

Peter M. Buonomo · Peter M. Buonomo — Beneficial ownership · 2.6%

Exact source ownership column: Pre-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Percent Owned; source holder: Peter M. Buonomo(2)

0001104659-26-111104 · SEC table 22 row 5 columns 12; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:7 ↗

Peter M. Buonomo · Peter M. Buonomo — Beneficial ownership · 1.6%

Exact source ownership column: Post-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Percent Owned; source holder: Peter M. Buonomo(2)

0001104659-26-111104 · SEC table 22 row 5 columns 24; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:13 ↗

Scott S. Robinson · Scott S. Robinson — Beneficial ownership · 1.3%

Exact source ownership column: Pre-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Percent Owned; source holder: Scott S. Robinson(3)

0001104659-26-111104 · SEC table 22 row 6 columns 12; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:7 ↗

Scott S. Robinson · Scott S. Robinson — Beneficial ownership · 0.8%

Exact source ownership column: Post-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Percent Owned; source holder: Scott S. Robinson(3)

0001104659-26-111104 · SEC table 22 row 6 columns 24; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:13 ↗

Christopher J. Turnbull · Christopher J. Turnbull — Beneficial ownership · 3.9%

Exact source ownership column: Pre-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Percent Owned; source holder: Christopher J. Turnbull(4)

0001104659-26-111104 · SEC table 22 row 7 columns 12; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:7 ↗

Christopher J. Turnbull · Christopher J. Turnbull — Beneficial ownership · 2.5%

Exact source ownership column: Post-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Percent Owned; source holder: Christopher J. Turnbull(4)

0001104659-26-111104 · SEC table 22 row 7 columns 24; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:13 ↗

Todd C. Johnson · Todd C. Johnson — Beneficial ownership · 9.7%

Exact source ownership column: Pre-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Percent Owned; source holder: Todd C. Johnson(5)

0001104659-26-111104 · SEC table 22 row 8 columns 12; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:7 ↗

Todd C. Johnson · Todd C. Johnson — Beneficial ownership · 6.2%

Exact source ownership column: Post-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Percent Owned; source holder: Todd C. Johnson(5)

0001104659-26-111104 · SEC table 22 row 8 columns 24; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:13 ↗

Executive Officers and Directors as a Group (6 persons) · Executive Officers and Directors as a Group (6 persons) — Beneficial ownership · 41.9%

Exact source ownership column: Pre-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Pre-Offering; Percent Owned; source holder: Executive Officers and Directors as a Group (6 persons)

0001104659-26-111104 · SEC table 22 row 10 columns 12; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:4,2:7 ↗

Executive Officers and Directors as a Group (6 persons) · Executive Officers and Directors as a Group (6 persons) — Beneficial ownership · 27%

Exact source ownership column: Post-Offering; Percent Owned; holders may overlap; not an additive partition

Raw source column: Post-Offering; Percent Owned; source holder: Executive Officers and Directors as a Group (6 persons)

0001104659-26-111104 · SEC table 22 row 10 columns 24; source 994841:1020777; SHA256 091630d680ce64383d3e560cb779f4163da0ee151f2f6f2ffd7e3fa5aa2b4c7b; ownership header cells 1:7,2:13 ↗

our officers and directors · our officers and directors — Ownership as disclosed · approximately 27.0%

Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares), of which Mr. Marino, our Chairman and CEO, will own, when combined with family members’ ownership, approximately 15.5% of our outstanding common stock following comple; source scope: of our outstanding common stock based on the SEC’s beneficial ownership rules (assuming no exercise of the underwriters’ option to purchase additional shares), of which Mr; not an additive ownership partition

Upon completion of this offering, our officers and directors collectively will own approximately 27.0% of our outstanding common stock based on the SEC’s beneficial ownership rules (assuming no exercise of the underwriters’ option to purchase additional shares), of which Mr. Marino, our Chairman and CEO, will own, when combined with family members’ ownership, approximately 15.5% of our outstanding common stock following completion of the offering (assuming no exercise of the underwriters’ option to purchase additional shares). As such, our officers and directors will have significant influence in determining the outcome of any matters submitted to shareholders for approval, including the election of directors and any merger, consolidation, sale of all or substantially all of our assets, or other significant corporate transactions. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interests as a shareholder.

0001104659-26-111104 · SEC ownership paragraph; source 334672:335869; SHA256 2fa3dba90e8e1b6d285a7695fb097f1536f5c149d04c5a3c3d3959f5e9d14cf3 ↗

Mr. Marino — when combined with family members’ ownership · Mr. Marino — when combined with family members’ ownership — Ownership as disclosed · approximately 15.5%

Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares); source scope: of our outstanding common stock following completion of the offering (assuming no exercise of the underwriters’ option to purchase additional shares); not an additive ownership partition

Upon completion of this offering, our officers and directors collectively will own approximately 27.0% of our outstanding common stock based on the SEC’s beneficial ownership rules (assuming no exercise of the underwriters’ option to purchase additional shares), of which Mr. Marino, our Chairman and CEO, will own, when combined with family members’ ownership, approximately 15.5% of our outstanding common stock following completion of the offering (assuming no exercise of the underwriters’ option to purchase additional shares). As such, our officers and directors will have significant influence in determining the outcome of any matters submitted to shareholders for approval, including the election of directors and any merger, consolidation, sale of all or substantially all of our assets, or other significant corporate transactions. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interests as a shareholder.

0001104659-26-111104 · SEC ownership paragraph; source 334672:335869; SHA256 2fa3dba90e8e1b6d285a7695fb097f1536f5c149d04c5a3c3d3959f5e9d14cf3 ↗

common stock · common stock — per-share voting rights · 1 vote per share

Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding

Holders of common stock have no preemptive, subscription, redemption or conversion rights. Cumulative voting for directors is not permitted, but the holders of common stock are entitled to one vote per share in all matters to be voted on by shareholders. Subject to the rights of the holders of any outstanding Preferred Stock, holders of common stock are entitled to receive dividends legally available therefore, when, as and if declared by the Board of Directors and, upon liquidation or dissolution of the Company, whether voluntary or involuntary, to share equally in the assets of the Company available for distribution to the shareholders. The Company has never paid a cash dividend on its common stock and does not intend to pay dividends in the foreseeable future. The Company’s present intention is to retain all future earnings for use in its business. All shares of common stock presently outstanding are fully paid and non-assessable. The Board of Directors is authorized to issue additional shares of common stock, but not to exceed the amount authorized by the Company’s Articles, and to issue options and warrants for the purchase of such shares, on such terms and conditions and for such consideration as the Board may deem appropriate without further shareholder action.

0001104659-26-111104 · SEC ownership paragraph; source 1029004:1030472; SHA256 56689867b4f5a491399f9557309af07e2306a69da78cdcbad8f3febf400eae16 ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Source lock-up conditions

Literal day restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stockAfter date of this prospectus · Source conditions apply180 days
Source and calculation
We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock

We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock have agreed with the underwriters, subject to certain exceptions, not to sell or transfer any common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus (the “Restricted Period”), except with the prior written consent of the Representative.

SEC lock-up paragraph; source 1097674:1098374; SHA256 0d6ff8ed7d80495540627edf66928a4a90fa97f7504bc3be93108ee582447d0e ↗

Conditional lock-up timeline

Conditional lock-up timeline

Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.

date of this prospectus

  1. We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stockWe and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock have agreed with the underwriters, subject to certain exceptions, not to sell or transfer any common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus (the “Restricted Period”), except with the prior written consent of the Representative.
Holder / event
Holder / eventTerm / dateConditions
We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock180 daysWe and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock have agreed with the underwriters, subject to certain exceptions, not to sell or transfer any common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus (the “Restricted Period”), except with the prior written consent of the Representative.
Basis and evidence
We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock

We and our executive officers, directors and shareholders holding 2% or more of the company’s outstanding common stock have agreed with the underwriters, subject to certain exceptions, not to sell or transfer any common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus (the “Restricted Period”), except with the prior written consent of the Representative.

SEC lock-up paragraph; source 1097674:1098374; SHA256 0d6ff8ed7d80495540627edf66928a4a90fa97f7504bc3be93108ee582447d0e ↗

Financial quality

Bars compare absolute amounts within each measure. Each measure has its own scale.

Revenue

USD · Annual values as reported
FY2024USD 2,134,528
FY2025USD 2,585,858

Net income / (loss)

USD · Annual values as reported
FY2024(USD 1,845,951)
FY2025(USD 928,088)

Operating cash flow

USD · Annual values as reported
FY2024(USD 462,270)
FY2025(USD 668,073)
Financial quality
CalculationFY2024FY2025
RevenueUSD 2,134,528USD 2,585,858
Net income / (loss)(USD 1,845,951)(USD 928,088)
Operating cash flow(USD 462,270)(USD 668,073)
Financial quality
CalculationReported valueReference
Current assets2025-12-31USD 1,802,293December 31, 2025; issuer; USD; as of 2025-12-31
Current assets2024-12-31USD 1,010,463December 31, 2024; issuer; USD; as of 2024-12-31
Total assets2025-12-31USD 2,160,381December 31, 2025; issuer; USD; as of 2025-12-31
Total assets2024-12-31USD 1,450,053December 31, 2024; issuer; USD; as of 2024-12-31
Current liabilities2025-12-31USD 3,568,779December 31, 2025; issuer; USD; as of 2025-12-31
Current liabilities2024-12-31USD 1,011,277December 31, 2024; issuer; USD; as of 2024-12-31
Total liabilities2025-12-31USD 3,830,090December 31, 2025; issuer; USD; as of 2025-12-31
Total liabilities2024-12-31USD 2,358,049December 31, 2024; issuer; USD; as of 2024-12-31
Total equity / (deficit)2025-12-31(USD 1,669,709)December 31, 2025; issuer; USD; as of 2025-12-31
Total equity / (deficit)2024-12-31(USD 907,996)December 31, 2024; issuer; USD; as of 2024-12-31
Current assets2026-06-30 · UnauditedUSD 1,472,257June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Current assets2025-12-31 · UnauditedUSD 1,802,293December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Total assets2026-06-30 · UnauditedUSD 1,786,441June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total assets2025-12-31 · UnauditedUSD 2,160,381December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Current liabilities2026-06-30 · UnauditedUSD 3,846,347June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Current liabilities2025-12-31 · UnauditedUSD 3,568,779December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Total liabilities2026-06-30 · UnauditedUSD 4,060,291June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total liabilities2025-12-31 · UnauditedUSD 3,830,090December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Total equity / (deficit)2026-06-30 · Unaudited(USD 2,273,850)June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total equity / (deficit)2025-12-31 · Unaudited(USD 1,669,709)December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Revenue6M ended 2026-06-30 · UnauditedUSD 557,3956M ended 2026-06-30; issuer unaudited; USD; 6 months ended 2026-06-30
Revenue6M ended 2025-06-30 · UnauditedUSD 1,010,0926M ended 2025-06-30; issuer unaudited; USD; 6 months ended 2025-06-30
Net income / (loss)6M ended 2026-06-30 · Unaudited(USD 610,965)6M ended 2026-06-30; issuer unaudited; USD; 6 months ended 2026-06-30
Net income / (loss)6M ended 2025-06-30 · Unaudited(USD 240,750)6M ended 2025-06-30; issuer unaudited; USD; 6 months ended 2025-06-30
Operating cash flow6M ended 2026-06-30 · Unaudited(USD 14,485)6M ended 2026-06-30; issuer unaudited; USD; 6 months ended 2026-06-30
Operating cash flow6M ended 2025-06-30 · Unaudited(USD 312,966)6M ended 2025-06-30; issuer unaudited; USD; 6 months ended 2025-06-30
Basis and evidence
Total Current Assets
December 31, 2025; issuer; USD; as of 2025-12-31
Total Current Assets
December 31, 2024; issuer; USD; as of 2024-12-31
TOTAL ASSETS
December 31, 2025; issuer; USD; as of 2025-12-31
TOTAL ASSETS
December 31, 2024; issuer; USD; as of 2024-12-31
Total current liabilities
December 31, 2025; issuer; USD; as of 2025-12-31
Total current liabilities
December 31, 2024; issuer; USD; as of 2024-12-31
Total liabilities
December 31, 2025; issuer; USD; as of 2025-12-31
Total liabilities
December 31, 2024; issuer; USD; as of 2024-12-31
Total stockholders’ equity (deficit)
December 31, 2025; issuer; USD; as of 2025-12-31
Total stockholders’ equity (deficit)
December 31, 2024; issuer; USD; as of 2024-12-31
Net Sales
FY2025; issuer; USD; year ended 2025-12-31
Net Sales
FY2024; issuer; USD; year ended 2024-12-31
Net Loss
FY2025; issuer; USD; year ended 2025-12-31
Net Loss
FY2024; issuer; USD; year ended 2024-12-31
Net Cash Used in Operating Activities
FY2025; issuer; USD; year ended 2025-12-31
Net Cash Used in Operating Activities
FY2024; issuer; USD; year ended 2024-12-31
Total Current Assets
June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total Current Assets
December 31, 2025; issuer unaudited; USD; as of 2025-12-31
TOTAL ASSETS
June 30, 2026; issuer unaudited; USD; as of 2026-06-30
TOTAL ASSETS
December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Total current liabilities
June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total current liabilities
December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Total liabilities
June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total liabilities
December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Total stockholders’ equity (deficit)
June 30, 2026; issuer unaudited; USD; as of 2026-06-30
Total stockholders’ equity (deficit)
December 31, 2025; issuer unaudited; USD; as of 2025-12-31
Net Sales
6M ended 2026-06-30; issuer unaudited; USD; 6 months ended 2026-06-30
Net Sales
6M ended 2025-06-30; issuer unaudited; USD; 6 months ended 2025-06-30
Net Loss
6M ended 2026-06-30; issuer unaudited; USD; 6 months ended 2026-06-30
Net Loss
6M ended 2025-06-30; issuer unaudited; USD; 6 months ended 2025-06-30
Net Cash Used in Operating Activities
6M ended 2026-06-30; issuer unaudited; USD; 6 months ended 2026-06-30
Net Cash Used in Operating Activities
6M ended 2025-06-30; issuer unaudited; USD; 6 months ended 2025-06-30
Financial quality and runway
Financial review

Financial quality and runway

Latest supplied period is the unaudited six months ended June 30, 2026. Revenue was $557,395 and net loss was $610,965. The filing also reports $79,771 cash and a substantial doubt regarding going concern; complete debt and operating-cash-flow amounts are not supplied in the excerpts.

Total Current AssetsUSD 1,802,293
Total Current AssetsUSD 1,010,463
TOTAL ASSETSUSD 2,160,381
EvidenceFinancial review 1

Six-month 2026 revenue declined from $1,010,092 in the comparable six-month 2025 period in the supplied table.

EvidenceFinancial review 2

The company reported a 2025 audited net loss of $928,088 and a six-month 2026 unaudited net loss of $610,965.

EvidenceFinancial review 3

The auditor’s 2025 report includes an explanatory paragraph raising substantial doubt about continuation for the following 12 months.

LATEST COMPARISON

Baseline filing — comparison pending

No source-comparable material changes identified in this report.

Open S-1/A ↗

No source-comparable material changes identified in this report.

IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 1

The company has no U.S. marketing approval; failure or delay in the stroke trial and PMA process could prevent U.S. commercialization.

Risk 2

The auditor’s going-concern doubt and management’s need for additional equity financing create a material funding dependency.

Risk 3

Product liability events could cause legal costs, recalls, regulatory scrutiny and loss of physician or patient confidence.

Evidence
Business ↗
Risk 4

The company faces competition from larger medical-device companies with greater financial, technical, regulatory and distribution resources.

Evidence
Business ↗
DocumentS-1/A0001104659-26-111104
Filed2026-09-28SEC EDGAR
Research updated2026-09-28Analysed
Source-bound table inputs66SEC EDGAR
Open filing ↗